Sfoglia per Rivista HAEMATOLOGICA
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins
2023 E. Taiana, C. Bandini, V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, K. Todoerti, S. Erratico, D. Giannandrea, N. Bolli, N. Amodio, A. Ciarrocchi, R. Chiaramonte, Y. Torrente, R. Piva, A. Neri
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment
2021 D. Soncini, C. Martinuzzi, P. Becherini, E. Gelli, S. Ruberti, K. Todoerti, L. Mastracci, P. Contini, A. Cagnetta, A. Laudisi, F. Guolo, P. Minetto, M. Miglino, S. Aquino, R. Varaldo, D. Reverberi, M. Formica, M. Passalacqua, A. Nencioni, A. Neri, M.K. Samur, N.C. Munshi, M. Fulciniti, R.M. Lemoli, M. Cea
Associations between gender, disease features and symptom burden in the MPN population : An analysis by the MPN QOL International Working Group
2017 H. Geyer, H. Kosiorek, A. Dueck, R. Scherber, S. Slot, S. Zweegman, P. Te Boekhorst, Z. Senyak, H. Schouten, F. Sackmann, A. Kerguelen Fuentes, D. Hernández Maraver, H. Pahl, M. Griesshammer, F. Stegelmann, K. Döhner, T. Lehmann, K. Bonatz, A. Reiter, F. Boyer, G. Etienne, J. Ianotto, D. Ranta, L. Roy, J. Cahn, C. Harrison, D. Radia, P. Muxi, N. Maldonado, C. Besses, F. Cervantes, P. Johansson, T. Barbui, G. Barosi, A. Vannucchi, C. Paoli, F. Passamonti, B. Andreasson, M. Ferrari, A. Rambaldi, J. Samuelsson, K. Cannon, G. Birgegard, Z. Xiao, Z. Xu, Y. Zhang, X. Sun, J. Xu, J. Kiladjian, P. Zhang, R. Gale, R. Mesa
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
2020 F. Maura, A. Dodero, C. Carniti, N. Bolli, M. Magni, V. Monti, A. Cabras, D. Leongamornlert, F. Abascal, B. Diamond, B. Rodriguez-Martin, J. Zamora, A. Butler, I. Martincorena, J.M.C. Tubio, P.J. Campbell, A. Chiappella, G. Pruneri, P. Corradini
COVID-19 in adult acute myeloid leukemia patients: a long-term followup study from the European Hematology Association survey (EPICOVIDEHA)
2023 F. Marchesi, J. Salmanton-García, Z. Emarah, K. Piukovics, M. Nucci, A. López-García, Z. Ráčil, F. Farina, M. Popova, S. Zompi, E. Audisio, M. Ledoux, L. Verga, B. Weinbergerová, T. Szotkovski, M.G. Da Silva, N. Fracchiolla, N. De Jonge, G. Collins, M. Marchetti, G. Magliano, C. García-Vidal, M.M. Biernat, J. Van Doesum, M. Machado, F. Demirkan, M. Al-Khabori, P. Žák, B. Víšek, I. Stoma, G. Méndez, J. Maertens, N. Khanna, I. Espigado, G. Dragonetti, L. Fianchi, M.I. Del Principe, A. Cabirta, I. Ormazabal-Vélez, O. Jaksic, C. Buquicchio, V. Bonuomo, J. Batinić, A.S. Omrani, S. Lamure, O. Finizio, N. Fernández, I. Falces-Romero, O. Blennow, R. Bergantim, N. Ali, S. Win, J. Van Praet, M.C. Tisi, A. Shirinova, M. Schönlein, J. Prattes, M. Piedimonte, V. Petzer, M. Navrátil, A. Kulasekararaj, P. Jindra, J. Sramek, A. Glenthøj, R. Fazzi, C. De Ramón-Sánchez, C. Cattaneo, M. Calbacho, N.C. Bahr, S. El-Ashwah, R. Cordoba, M. Hanakova, G. Zambrotta, M. Sciumè, S. Booth, R.N. Rodrigues, M.V. Sacchi, N. García-Poutón, J. Martín-González, S. Khostelidi, S. Gräfe, L. Rahimli, E. Ammatuna, A. Busca, P. Corradini, M. Hoenigl, N. Klimko, P. Koehler, A. Pagliuca, F. Passamonti, O.A. Cornely, L. Pagano
{COVID}-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus {ALL} report
2022 S. Chiaretti, M. Bonifacio, R. Agrippino, F. Giglio, M. Annunziata, A. Curti, M. Ilaria Del Principe, P. Salutari, M. Scium(`(e)), M. Delia, M. Armenio, V. Mancini, A. Mul(`(e)), F. Grimaldi, G. Rege-Cambrin, L. Santoro, F. Lussana, P. Chiusolo, C. Pasciolla, A. Maria Scattolin, M. Cerrano, M. Ciccone, M. Defina, F. Forghieri, C.M. Mazzone, M. Piccini, F. Ferrara, G. Pizzolo, R. Fo(`(a))
Cutaneous T-cell lymphomas (including rare subtypes) : current concepts. II
2004 M. Paulli, E. Berti
Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma
2022 A.N. Bastidas Torres, D. Cats, J.J. Out-Luiting, D. Fanoni, H. Mei, L. Venegoni, R. Willemze, M.H. Vermeer, E. Berti, C.P. Tensen
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification
2023 V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, G. Fabbiano, V. Traini, K. Todoerti, S. Erratico, A. Ciarrocchi, V. Fragliasso, D. Giannandrea, F. Tumiatti, R. Chiaramonte, Y. Torrente, P. Finelli, E. Morelli, N.C. Munshi, N. Bolli, A. Neri, E. Taìana
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome
2021 K. Todoerti, D. Ronchetti, V. Favasuli, F. Maura, F. Morabito, N. Bolli, E. Taiana, A. Neri
Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome
2021 A. Dodero, A. Guidetti, F. Marino, A. Tucci, F. Barretta, A. Re, M. Balzarotti, C. Carniti, C. Monfrini, A. Chiappella, A. Cabras, F. Facchetti, M. Pennisi, D. Rahal, V. Monti, L. Devizzi, R. Miceli, F. Cocito, L. Farina, F. Ricci, G. Rossi, C. Carlo-Stella, P. Corradini
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way
2022 D. Giannandrea, N. Platonova, M. Colombo, M. Mazzola, V. Citro, R. Adami, F. Maltoni, S. Ancona, V. Dolo, I. Giusti, A. Basile, A. Pistocchi, L. Cantone, V. Bollati, L. Casati, E. Calzavara, M. Turrini, E. Lesma, R. Chiaramonte
The factor VIII/von Willebrand factor complex: basic and clinical issues
2003 A. Federici
A homozygous duplication of the FGG exon 8-intron 8 junction causes congenital afibrinogenemia. Lessons learned from the study of a large consanguineous Turkish family
2021 M. Guipponi, F. Masclaux, F. Sloan-Béna, C. Di Sanza, N. Özbek, F. Peyvandi, M. Menegatti, A. Casini, B. Malbora, M. Neerman-Arbez
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia
2021 S. Bonato, A. Artoni, A. Lecchi, G. Schwarz, S. La Marca, L. Padovan, M. Clerici, C. Guadino, G.P. Comi, A. Tripodi, F. Peyvandi
A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications
2004 L. Hilbert, A. Federici, L. Baronciani, S. Dallagiovanna, C. Mazurier
Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdO×1 nCov-19 vaccine
2021 M. Scavone, B. Clerici, S. Birocchi, T. Mencarini, M. Calogiuri, C. Ghali, D. Prati, S. Bozzi, P. Villa, M. Cattaneo, G.M. Podda
A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents
2023 R. Mina, M.T. Petrucci, F. Bonello, V. Bongarzoni, R. Saccardi, G. Bertuglia, A. Mengarelli, A. Spadaro, C. Lisi, P. Curci, R.M. Lemoli, S. Ballanti, R. Floris, L. Cupelli, P. Tosi, A. Olivieri, D. Rota-Scalabrini, C. Cangialosi, C. Nozzoli, B. Anaclerico, F. Fazio, B. Bruno, K. Mancuso, P. Corradini, G. Milone, M. Boccadoro
Pulmonary dysfunction in thalassemia major and correlations with body iron stores
2015 F. Guidotti, G. Piatti, A. Marcon, E. Cassinerio, V. Fasano, A. Roghi, L. Zanaboni, M.D. Cappellini
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen
2022 P. Simeone, R. Liani, R. Tripaldi, S. Ciotti, A. Recchiuti, V. Abbonante, B. Porro, P. Del Boccio, A. Di Castelnuovo, P. Lanuti, M. Camera, D. Pieragostino, M. Lee-Sundlov, M. Luongo, R. Auciello, G. Bologna, M.C. Cufaro, E. Tremoli, K.M. Hoffmeister, F. Cipollone, A. Balduini, F. Santilli
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile